CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
CareDx is seeking a motivated and curious Biostatistics Intern to join our Biostatistics team in Brisbane, CA. This internship is well‐suited for undergraduate and graduate students who are eager to apply their classroom learning to real‐world problems in the biotech industry while gaining hands‐on experience with clinical and observational data.
What You’ll Do
As a Biostatistics Intern, you will work closely with an experienced, senior‐level statistician on a meaningful research project tied to real clinical and scientific questions. You’ll gain practical exposure to how statistical methods are used in industry, learn how to work with real‐world datasets, and develop skills that prepare you for future roles in biostatistics, data science, or related fields.
This role is designed to be a learning‐focused, supportive experience where interns are encouraged to ask questions, build confidence, and grow their technical and communication skills.
Key Responsibilities
- Support a senior‐level statistician on a statistical research project related to real‐world biotech and clinical challenges
- Apply appropriate statistical methods to analyze and interpret data
- Learn how to evaluate and summarize clinical evidence using real‐world data
- Present your research findings at the end of the internship program
- Potentially contribute to a written research summary or manuscript, with possible submission to a peer‐reviewed publication
What You’ll Gain
- Hands‐on experience working with real clinical and real‐world data
- One‐on‐one mentorship from experienced biostatistics professionals
- Exposure to industry‐based research beyond academic coursework
- Experience presenting technical work in a professional setting
- A strong foundation for future internships, graduate programs, or entry‐level roles
Qualifications
- Currently enrolled undergraduate or graduate student in Statistics, Biostatistics, Data Science, Computer Science, Epidemiology, Public Health, Mathematics, or a related field
- Good academic standing (minimum cumulative GPA of 3.0 on a 4.0 scale)
- Completion of at least 12 credit hours in a related major and/or relevant coursework
- Familiarity with statistical analysis using SAS and/or R (academic or project‐based experience is acceptable)
- Strong written and verbal communication skills, with interest in learning how to present analytical findings
CareDx, Inc. is an Equal Opportunity Employer-vets/disabled, and participates in the E-Verify program.
By proceeding with our application and submitting your information, you acknowledge that you have read our U.S. Personnel Privacy Notice and consent to receive email communication from CareDx.
***We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.***
Certain jurisdictions require notice of how we use and protect your personal information. For more information, please read our Privacy Policy
This is the anticipated base salary range for candidates who will work in Brisbane, California. The final salary offered to a successful candidate will be dependent on several factors that may include, but are not limited to, the type and length of experience within the job, the type and length of experience within the industry, education, etc. Base pay is one part of the Total Package that is provided to compensate and recognize employees for their work, and this role may be eligible for additional discretionary bonuses/incentives and restricted stock units. CareDx is a multi-state employer, and this salary range may not reflect positions that work in other states.
Similar Jobs
What We Do
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
